» Articles » PMID: 38586872

Microbes Identified from Monitoring Cell Manipulations in 5-year Life of the Cell Factory G. Gaslini

Overview
Journal Regen Ther
Date 2024 Apr 8
PMID 38586872
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Quality and safety of a cell product, essential to guarantee the health of patients, depends on many factors including an appropriate environmental monitoring of the manufacturing rooms. Nonetheless, the maintenance of a controlled environment is requested to minimize the risk of contamination. Thus, a timely detection of changes in microbiological trends is important to adopt promptly effective measures against resistant strains that, in turn, may invalidate not only the sanitization procedures but also the safety of the cell product.

Methods: We analyzed microbes found in our cell processing clean room over the last 5 years. We used 10.147 plates for air sampler, passive air monitoring and for checking instruments and operators of the production unit.

Results: From these plates, 747 colonies were subjected to identification by the MALDI-TOF Vitek® MS system and the large majority of them was gram positive (97.8%) as witnessed by the finding that the most represented harvested from the classified areas were (65%), (13%), (8%) and (5%). We never detected fungi. Most microbes found in the operators (both from class A and B) were collected from forearms and resulted of the

Conclusions: The observed microbial contamination is to be attributed to the personnel and no substantial microbial pitfalls in our Cell Factory has been detected.

Citing Articles

Changeover method for biosafety cabinets using ozone gas.

Mizuno M, Suda D, Matsumura C, Sekiya I PLoS One. 2025; 20(1):e0318006.

PMID: 39874382 PMC: 11774351. DOI: 10.1371/journal.pone.0318006.


Cleaning methods for biosafety cabinet to eliminate residual mycoplasmas, viruses, and endotoxins after changeover.

Mizuno M, Kimbara S, Ichise H, Ishikawa N, Nishihara Y, Nishio M Regen Ther. 2024; 28:73-80.

PMID: 39703815 PMC: 11655690. DOI: 10.1016/j.reth.2024.11.020.


Approach of design for air mass balance in an aseptic processing area for cell-based products.

Furomitsu S, Mizutani M, Kino-Oka M Regen Ther. 2024; 28:20-29.

PMID: 39664364 PMC: 11629579. DOI: 10.1016/j.reth.2024.11.009.

References
1.
Cobo F, Cortes J, Cabrera C, Nieto A, Concha A . Microbiological contamination in stem cell cultures. Cell Biol Int. 2007; 31(9):991-5. DOI: 10.1016/j.cellbi.2007.03.010. View

2.
Mizutani M, Samejima H, Terunuma H, Kino-Oka M . Experience of contamination during autologous cell manufacturing in cell processing facility under the Japanese Medical Practitioners Act and the Medical Care Act. Regen Ther. 2019; 5:25-30. PMC: 6581811. DOI: 10.1016/j.reth.2016.06.004. View

3.
Sandle T . Examination of the order of incubation for the recovery of bacteria and fungi from pharmaceutical-grade cleanrooms. Int J Pharm Compd. 2014; 18(3):242-7. View

4.
Cundell A . Microbial identification strategies in the pharmaceutical industry. PDA J Pharm Sci Technol. 2006; 60(2):111-23. View

5.
Sandle T . A review of cleanroom microflora: types, trends, and patterns. PDA J Pharm Sci Technol. 2012; 65(4):392-403. DOI: 10.5731/pdajpst.2011.00765. View